Radiographic Progression in Sacroiliac Joints in Patients With Axial Spondyloarthritis: Results From a Five‐Year International Observational Study
ACR Open Rheumatology · 2024-02 · 6 (2) · 103-110
DOI: 10.1002/acr2.11642 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACR Open Rheumatology, online erschienen am 18.12.2023. Verfasst von Denis Poddubnyy und 9 weiteren Autor:innen. Beteiligte Einrichtung: Charité-Universitätsmedizin Berlin and German Rheumatism Research Center, Berlin, Germany. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: AbbVie.
Abstract (Originalsprache)
Objective
To evaluate progression from nonradiographic (nr‐) to radiographic axial spondyloarthritis (r‐axSpA) over 5 years in patients with recently diagnosed (≤1 year) axSpA fulfilling the Assessment of SpondyloArthritis international Society (ASAS) classification criteria.
Methods
A prospsective, observational study (Patients with Axial Spondyloarthritis: Multi‐Country Registry of Clinical Characteristics) was conducted in rheumatology practices in 29 countries. Baseline and follow‐up radiographs of sacroiliac joints were centrally evaluated by three readers according to the grading system of the modified New York criteria for patients initially classified as nr‐axSpA. Radiographic progression from nr‐axSpA to r‐axSpA was evaluated by Kaplan‐Meier analysis. Cox proportional regression analyses for progression from nr‐axSpA to r‐axSpA were also conducted.
Results
Among 2,165 patients with axSpA, 1,612 (74%) were classified as having r‐axSpA (1,050 [65%]) or nr‐axSpA (562 [35%]) by central reading. Of 246 patients with nr‐axSpA (mean [SD] symptom duration: 4.4 [6.2] years) who had at least one follow‐up sacroiliac joint radiograph, progression from nr‐axSpA to r‐axSpA at any follow‐up visit was observed in 40 patients (16%) over 5 years. Mean time to radiographic progression was 2.4 years (ranging from 0.9 to 5.1 years). Progression to r‐axSpA was associated with male sex (hazard ratio [HR] 3.16 [95% CI 1.22–8.17]), fulfillment of the imaging arm of the ASAS classification criteria (HR 6.64 [1.37–32.25]), and good response to nonsteroidal anti‐inflammatory drugs (HR 4.66 [1.23–17.71]).
Conclusion
16% of patients with nr‐axSpA progressed to r‐axSpA within 5 years. Male sex, fulfillment of the imaging arm of the ASAS criteria, and good response to nonsteroidal anti‐inflammatory drugs were predictors of radiographic progression in patients with recently diagnosed axSpA.
Autor:innen und Institutionen
- Charité-Universitätsmedizin Berlin and German Rheumatism Research Center, Berlin, Germany.
- Charité-Universitätsmedizin Berlin, Berlin, Germany.
- Izmir Katip Celebi University, Izmir, Turkey.
- Hospital Universitario Infanta Sofía, Universidad Europea, Madrid, Spain.
- GKM Gesellschaft für Therapieforschung mbH, Munich, Germany.
- AbbVie Inc., Baar, Switzerland.
ORCID-Profile: Denis Poddubnyy
Förderung
- AbbVie
Zitieren
APA
Poddubnyy, D., Sieper, J., Akar, S., Muñoz-Fernández, S., Haibel, H., Diekhoff, T., Protopopov, M., Altmaier, E., Ganz, F., & Inman, R. D. (2024). Radiographic Progression in Sacroiliac Joints in Patients With Axial Spondyloarthritis: Results From a Five‐Year International Observational Study. ACR Open Rheumatology, 6(2), 103-110. https://doi.org/10.1002/acr2.11642
Vancouver
Poddubnyy D, Sieper J, Akar S, Muñoz-Fernández S, Haibel H, Diekhoff T, et al. Radiographic Progression in Sacroiliac Joints in Patients With Axial Spondyloarthritis: Results From a Five‐Year International Observational Study. ACR Open Rheumatology. 2024;6(2):103-110. doi:10.1002/acr2.11642
BibTeX
@article{Poddubnyy2024,
author = {Poddubnyy, Denis and Sieper, Joachim and Akar, Servet and Muñoz-Fernández, Santiago and Haibel, Hildrun and Diekhoff, Torsten and Protopopov, Mikhail and Altmaier, Elisabeth and Ganz, Fabiana and Inman, Robert D},
title = {Radiographic Progression in Sacroiliac Joints in Patients With Axial Spondyloarthritis: Results From a Five‐Year International Observational Study},
journal = {ACR Open Rheumatology},
year = {2024},
volume = {6},
number = {2},
pages = {103--110},
doi = {10.1002/acr2.11642}
}
EUVIMED